SC
BIO icon

SRB Corp’s Bio-Rad Laboratories Class A BIO Stock Holding History

SRB Corp’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-1,805
Closed -$1.02M – 70
2022
Q1 		$1.02M Hold
1,805
– – 0.06% 113
2021
Q4 		$1.36M Sell
1,805
-376
-17% -$281K 0.07% 87
2021
Q3 		$1.63M Sell
2,181
-1,011
-32% -$757K 0.1% 43
2021
Q2 		$2.06M Buy
3,192
+672
+27% +$409K 0.13% 16
2021
Q1 		$1.44M Buy
2,520
+1,187
+89% +$703K 0.1% 85
2020
Q4 		$777K Buy
1,333
+212
+19% +$121K 0.06% 123
2020
Q3 		$577K Buy
+1,121
New +$568K 0.05% 67

Other funds holding BIO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VAM
Veritas Asset Management London, United Kingdom $5.56B AUM 3.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

SRB Corp's BIO Position: Q2 2022 in Review

SRB Corp sold out of Bio-Rad Laboratories Class A (BIO) in Q2 2022, closing a stake of 1,805 shares — an estimated $1.02M sold.

SRB Corp first reported a position in BIO in Q3 2020 and held it in 7 quarters. The position peaked at $2.06M in Q2 2021. 500 funds tracked by Wall St. Rank hold BIO as of Q2 2022.

  • SRB Corp reported no remaining Bio-Rad Laboratories Class A position as of Q2 2022 after selling out during the quarter.
  • SRB Corp sold 1,805 Bio-Rad Laboratories Class A shares in Q2 2022, an estimated $1.02M.
  • SRB Corp first reported a position in Bio-Rad Laboratories Class A in Q3 2020 and held it in 7 quarters.
  • SRB Corp's Bio-Rad Laboratories Class A position peaked at $2.06M in Q2 2021.
  • 500 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q2 2022.

Based on SRB Corp's 13F filing for Q2 2022, filed 12 Aug 2022.